Title | Type | SJR | H index | Total Docs. (2002) | Total Docs. (3years) | Total Refs. (2002) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2002) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacology and Therapeutics | journal | 2.731 Q1 | 233 | 66 | 203 | 9004 | 1437 | 200 | 6.15 | 136.42 | |
2 | Drug Metabolism Reviews | journal | 1.060 Q1 | 108 | 34 | 88 | 3599 | 328 | 87 | 2.91 | 105.85 | |
3 | Expert Opinion on Emerging Drugs | journal | 0.270 Q2 | 54 | 25 | 68 | 2413 | 70 | 65 | 1.13 | 96.52 | |
4 | Expert Opinion on Investigational Drugs | journal | 0.790 Q1 | 117 | 134 | 790 | 12336 | 1907 | 769 | 2.57 | 92.06 | |
5 | Clinical Pharmacokinetics | journal | 1.347 Q1 | 184 | 93 | 224 | 7889 | 1228 | 216 | 5.12 | 84.83 | |
6 | Drug Resistance Updates | journal | 1.060 Q1 | 132 | 24 | 141 | 2029 | 378 | 134 | 2.54 | 84.54 | |
7 | Paediatric Drugs | journal | 0.444 Q2 | 70 | 72 | 124 | 5938 | 211 | 122 | 1.82 | 82.47 | |
8 | BioDrugs | journal | 0.329 Q2 | 79 | 47 | 230 | 3842 | 264 | 217 | 1.44 | 81.74 | |
9 | Drugs and Aging | journal | 0.880 Q1 | 109 | 71 | 234 | 5790 | 719 | 215 | 2.74 | 81.55 | |
10 | AIDS Reviews | journal | 0.409 Q2 | 62 | 22 | 50 | 1770 | 57 | 50 | 1.14 | 80.45 | |
11 | Drugs | journal | 1.177 Q1 | 188 | 195 | 738 | 14911 | 3374 | 646 | 5.49 | 76.47 | |
12 | Expert Opinion on Drug Safety | journal | 90 | 36 | 0 | 2683 | 0 | 0 | 0.00 | 74.53 | ||
13 | Side Effects of Drugs Annual | book series | 0.105 Q4 | 9 | 52 | 153 | 3813 | 9 | 153 | 0.07 | 73.33 | |
14 | Expert Opinion on Pharmacotherapy | journal | 0.423 Q2 | 93 | 160 | 273 | 11187 | 453 | 263 | 1.70 | 69.92 | |
15 | CNS Drugs | journal | 0.578 Q2 | 129 | 79 | 221 | 5490 | 475 | 210 | 2.17 | 69.49 | |
16 | American Journal of Cardiovascular Drugs | journal | 0.242 Q3 | 60 | 45 | 48 | 2948 | 19 | 41 | 0.40 | 65.51 | |
17 | Expert Review of Neurotherapeutics | journal | 0.162 Q3 | 98 | 93 | 28 | 5734 | 13 | 26 | 0.46 | 61.66 | |
18 | Primary Care - Clinics in Office Practice | journal | 0.427 Q2 | 59 | 60 | 167 | 3699 | 184 | 155 | 0.68 | 61.65 | |
19 | Adverse Drug Reaction Bulletin | journal | 0.159 Q3 | 8 | 5 | 18 | 302 | 2 | 18 | 0.17 | 60.40 | |
20 | Drugs of Today | journal | 0.173 Q3 | 57 | 74 | 326 | 4312 | 153 | 322 | 0.38 | 58.27 | |
21 | Drug Safety | journal | 1.006 Q1 | 140 | 96 | 253 | 5584 | 1068 | 245 | 4.10 | 58.17 | |
22 | Inflammopharmacology | journal | 0.149 Q3 | 68 | 33 | 90 | 1806 | 35 | 90 | 0.40 | 54.73 | |
23 | Cochrane Database of Systematic Reviews | journal | 0.623 Q1 | 327 | 393 | 1304 | 20852 | 3423 | 1304 | 2.65 | 53.06 | |
24 | Journal of Pharmacy Practice | journal | 0.103 Q4 | 38 | 49 | 151 | 2557 | 7 | 132 | 0.04 | 52.18 | |
25 | International Journal of Neuropsychopharmacology | journal | 0.794 Q1 | 125 | 47 | 137 | 2392 | 305 | 131 | 2.47 | 50.89 | |
26 | Drugs of the Future | journal | 0.355 Q2 | 46 | 87 | 269 | 4423 | 303 | 269 | 1.09 | 50.84 | |
27 | Clinical Research and Regulatory Affairs | journal | 0.117 Q4 | 18 | 24 | 58 | 1098 | 3 | 55 | 0.03 | 45.75 | |
28 | Today's Therapeutic Trends | journal | 0.142 Q3 | 13 | 22 | 69 | 944 | 24 | 69 | 0.20 | 42.91 | |
29 | Experimental and Clinical Psychopharmacology | journal | 0.916 Q1 | 101 | 54 | 176 | 2286 | 304 | 175 | 1.53 | 42.33 | |
30 | Journal of Biomedical Science | journal | 0.712 Q1 | 110 | 79 | 173 | 3317 | 405 | 172 | 2.60 | 41.99 | |
31 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.116 Q4 | 61 | 74 | 27 | 2985 | 12 | 24 | 0.44 | 40.34 | |
32 | European Neuropsychopharmacology | journal | 0.850 Q1 | 130 | 87 | 255 | 3509 | 580 | 234 | 2.20 | 40.33 | |
33 | Drug and Alcohol Dependence | journal | 1.265 Q1 | 187 | 129 | 371 | 5080 | 1072 | 360 | 2.72 | 39.38 | |
34 | Expert Review of Anticancer Therapy | journal | 0.149 Q3 | 85 | 112 | 89 | 4388 | 25 | 82 | 0.28 | 39.18 | |
35 | Alimentary Pharmacology and Therapeutics | journal | 1.192 Q1 | 207 | 249 | 687 | 9422 | 2743 | 659 | 3.88 | 37.84 | |
36 | Pulmonary Pharmacology and Therapeutics | journal | 0.728 Q1 | 81 | 77 | 139 | 2874 | 311 | 136 | 2.23 | 37.32 | |
37 | Alimentary Pharmacology and Therapeutics, Supplement | journal | 0.900 Q1 | 69 | 66 | 110 | 2435 | 355 | 98 | 1.81 | 36.89 | |
38 | Methods and Findings in Experimental and Clinical Pharmacology | journal | 0.240 Q3 | 56 | 114 | 326 | 4155 | 214 | 326 | 0.58 | 36.45 | |
39 | European Archives of Psychiatry and Clinical Neuroscience | journal | 1.009 Q1 | 111 | 51 | 201 | 1824 | 459 | 191 | 1.81 | 35.76 | |
40 | Cardiovascular Drugs and Therapy | journal | 0.480 Q2 | 79 | 75 | 218 | 2612 | 214 | 182 | 0.93 | 34.83 | |
41 | Current Treatment Options in Oncology | journal | 0.140 Q3 | 66 | 51 | 105 | 1762 | 22 | 105 | 0.21 | 34.55 | |
42 | Anti-Cancer Drugs | journal | 0.709 Q1 | 102 | 139 | 379 | 4781 | 818 | 377 | 2.22 | 34.40 | |
43 | Journal of Psychiatry and Neuroscience | journal | 0.887 Q1 | 114 | 42 | 154 | 1425 | 337 | 114 | 2.18 | 33.93 | |
44 | Drug Metabolism and Pharmacokinetics | journal | 75 | 65 | 0 | 2178 | 0 | 0 | 0.00 | 33.51 | ||
45 | BMC Pharmacology | journal | 0.192 Q3 | 48 | 21 | 13 | 702 | 11 | 13 | 0.85 | 33.43 | |
46 | Journal of Psychopharmacology | journal | 1.070 Q1 | 135 | 63 | 206 | 2077 | 530 | 179 | 2.72 | 32.97 | |
47 | Pharmacotherapy | journal | 0.705 Q1 | 126 | 231 | 684 | 7609 | 1545 | 649 | 2.26 | 32.94 | |
48 | Clinical Neuropharmacology | journal | 0.635 Q1 | 85 | 61 | 189 | 2009 | 379 | 182 | 1.87 | 32.93 | |
49 | Psychopharmacology Bulletin | journal | 0.431 Q2 | 66 | 62 | 37 | 2027 | 19 | 37 | 0.51 | 32.69 | |
50 | Therapeutic Drug Monitoring | journal | 0.541 Q2 | 102 | 118 | 344 | 3840 | 802 | 331 | 2.21 | 32.54 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®